(FNOV) FT Cboe Vest U.S. Equity - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
FNOV: Options, ETF, Stocks
The FT Cboe Vest U.S. Equity Buffer ETF - November (FNOV) is designed to provide investors with exposure to the S&P 500, but with a twist. It primarily invests in FLEX Options, which are highly customizable exchange-traded contracts. These options allow the fund to tailor terms like strike prices, expiration dates, and contract styles, giving it flexibility in managing risk and potential returns.
Under normal market conditions, the fund allocates nearly all its assets to these FLEX Options, which are linked to the SPDR S&P 500 ETF Trust. This structure is meant to offer a buffered outcome, balancing some downside protection with participation in upside gains. However, its important to note that the fund is non-diversified, meaning it can concentrate its investments in a smaller number of securities or strategies, which may increase risk.
For investors and fund managers, understanding the mechanics of FLEX Options is key. These instruments allow for precise hedging and risk management, but they also come with complexities. The funds approach is particularly relevant for those seeking defined outcomes in equity markets, as it aims to provide a specific risk-return profile rather than broad market exposure.
With an AUM of $960.90M, FNOV operates on the BATS exchange and falls under the Defined Outcome ETF category. This category has gained traction in recent years as investors seek strategies that balance risk and return in volatile markets. The funds structure and use of derivatives make it a specialized tool for portfolio construction.
Additional Sources for FNOV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FNOV ETF Overview
Market Cap in USD | 959m |
Category | Defined Outcome |
TER | 0.85% |
IPO / Inception | 2019-11-15 |
FNOV ETF Ratings
Growth 5y | 79.7% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -4.21 |
Analysts | - |
Fair Price Momentum | 46.63 USD |
Fair Price DCF | - |
FNOV Dividends
No Dividends PaidFNOV Growth Ratios
Growth Correlation 3m | -0.1% |
Growth Correlation 12m | 94% |
Growth Correlation 5y | 85.7% |
CAGR 5y | 12.88% |
CAGR/Max DD 5y | 0.81 |
Sharpe Ratio 12m | 0.94 |
Alpha | -1.38 |
Beta | 0.39 |
Volatility | 12.98% |
Current Volume | 111.5k |
Average Volume 20d | 24.6k |
As of March 13, 2025, the stock is trading at USD 46.53 with a total of 111,518 shares traded.
Over the past week, the price has changed by -2.71%, over one month by -4.75%, over three months by -4.19% and over the past year by +4.92%.
Yes. Based on ValueRay Analyses, FT Cboe Vest U.S. Equity (BATS:FNOV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 79.68 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FNOV as of March 2025 is 46.63. This means that FNOV is currently overvalued and has a potential downside of 0.21%.
FT Cboe Vest U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, FNOV FT Cboe Vest U.S. Equity will be worth about 51.1 in March 2026. The stock is currently trading at 46.53. This means that the stock has a potential upside of +9.74%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 51.1 | 9.7% |